Skip to main content
. 2022 Jun 9;102:676. doi: 10.2340/actadv.v102.676

Table I.

Sociodemographic features of the sample and characteristics of chronic spontaneous urticaria (CSU) (n = 75)

Characteristics
Socio-demographic features
Age, years, mean (SD) 46.48 (11.25)
Sex, % (n)
 Male 29.3 (22/75)
 Female 70.7 (53/75)
Marital status, % (n)
 In a couple 77.3 (58/75)
 Single 22.7 (17/75)
Occupation, % (n)
 Employed 78.7 (59/75)
 Unemployed 21.3 (16/75)
Educational level, % (n)
 Basic education 8 (6/75)
 Secondary education 13.3 (10/75)
 Professional education 28 (21/75)
 University education 50.7 (38/75)
Disease characteristics
Disease duration, years, mean (SD) 10.73 (10.69)
Urticaria Control Test score, mean (SD) 18.64 (6.90)
Disease duration, % (n)
 <10 years 60 (45/75)
 >10 years 40 (30/75)
Current treatment for CSU, % (n)
 Antihistamines 41.3 (31/75)
 Antihistamines + corticosteroids 6.7 (5/75)
 Corticosteroids 2.7 (2/75)
 Omalizumab 38.7 (29/75)
 No medical treatment 10.6 (8/75)
Quality of life indicators
 DLQI, mean (SD) 8.12 (7.15)
 DS14 (% of positive test), % (n) 28 (21/75)
 HADS Depression (% of positive test), % (n) 41.33 (31/75)
 FSFI (% of female sexual dysfunction), % (n) 54.54 (30/55)
 Overall CUQoL, mean (SD) 28.63 (21.73)
 PSQI, mean (SD) 9.53 (4.68)
 HADS Anxiety (% of positive test), % (n) 46.67 (35/75)
 IIEF (% of male sexual dysfunction), % (n) 63.63 (14/22)

CUQoL: Chronic Urticaria Quality of Life questionnaire; CSU: chronic spontaneous urticaria; DLQI: Dermatology Quality of Life Index; DS14: Type D-14 scale; FSFI Female Sexual Function Index; HADS: Hospital Anxiety and Depression Scale; IIEF: International Index of Erectile Function; PSQI: Pittsburg Sleep Quality Index; SD: standard deviation.